You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hyperlipoproteinemias

Showing 1 - 25 of 277
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Familial Hyperlipidemia Trial

Not yet recruiting
  • Familial Hyperlipidemia
    • (no location specified)
    Apr 12, 2023

    Cardiometabolic Disease, Hyperlipidemia Trial in Beijing (Telehealth integrated care, Conventional health care)

    Recruiting
    • Cardiometabolic Disease
    • Hyperlipidemia
    • Telehealth integrated care
    • Conventional health care
    • Beijing, Beijing, China
      Peking University Third Hospital
    Sep 1, 2023

    Type 1 Hyperlipoprotenemia Trial (Orlistat, Placebo)

    Not yet recruiting
    • Type 1 Hyperlipoprotenemia
    • (no location specified)
    Apr 14, 2023

    Hyperlipidemia, Hyperglycemia, Type 2 Diabetes Trial in Taipei (Adlay with white rice, white rice)

    Recruiting
    • Hyperlipidemia
    • +2 more
    • Adlay with white rice
    • white rice
    • Taipei, Taiwan
      National Taiwan University Hospital
    Aug 17, 2023

    Hyperlipidemias, Obesity, Body Fat Disorder Trial (Xian-Hua-Cha)

    Not yet recruiting
    • Hyperlipidemias
    • +2 more
    • (no location specified)
    Nov 20, 2022

    Hyperlipoproteinemia (a) Trial (Pelacarsen)

    Not yet recruiting
    • Hyperlipoproteinemia (a)
    • (no location specified)
    Jun 2, 2023

    Program With Lipid Screening asMeans to Identify Familial

    Enrolling by invitation
    • Familial Hyperlipidemia
      • Loveland, Colorado
        Medical Center of the Rockies
      Mar 2, 2023

      Hyperlipidemias Trial in Belfast (Fenugreek Seed Tea, Black Tea)

      Recruiting
      • Hyperlipidemias
      • Fenugreek Seed Tea
      • Black Tea
      • Belfast, Northern Ireland, United Kingdom
      • +1 more
      May 5, 2023

      Epilepsy, Hypertension, Hyperlipidemia (E.G., Hypercholesterolemia) Trial (Neurologist Initiated Treatment, Placebo)

      Not yet recruiting
      • Epilepsy
      • +2 more
      • Neurologist Initiated Treatment
      • Placebo
      • (no location specified)
      Jan 27, 2023

      Hyperlipidemias Trial in Derby (DASH eating plan with eggs, DASH eating plan without eggs)

      Recruiting
      • Hyperlipidemias
      • DASH eating plan with eggs
      • DASH eating plan without eggs
      • Derby, Connecticut
        Yale-Griffin Prevention Research Center
      Mar 28, 2023

      LDL Hyperlipoproteinemia, Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia, Triglyceride Storage Type I or II Disease

      Not yet recruiting
      • LDL Hyperlipoproteinemia
      • +2 more
      • omega-3 fatty acids
      • Placebo
      • Novosibirsk, Novosibisk Region, Russian Federation
        Center of New Medical Technologies
      Nov 30, 2023

      Hypertension, Hyperlipidemias Trial ((D) DWC202206, (D) DWC202207, (P) DWC202206)

      Not yet recruiting
      • Hypertension
      • Hyperlipidemias
      • (D) DWC202206
      • +3 more
      • (no location specified)
      Dec 8, 2022

      Hyperlipidemia Trial in Guangzhou (SHR-1209, Placebo)

      Completed
      • Hyperlipidemia
      • Guangzhou, Guangdong, China
        Sun Yat-Sen Memorial Hospital ,The Second Affiliated Hospital of
      Nov 29, 2022

      Hyperlipidemias Trial in Dhaka (Zinc sulfate, Placebo)

      Recruiting
      • Hyperlipidemias
      • Zinc sulfate
      • Placebo
      • Dhaka, Bangladesh
        Bangabandhu Sheikh Mujib Medical University
      May 24, 2022

      Hyperlipidemias Trial in Portland (Fruit and vegetable deliveries)

      Completed
      • Hyperlipidemias
      • Fruit and vegetable deliveries
      • Portland, Oregon
        Oregon Health & Science University
      Apr 18, 2022

      Dyslipidemias, Hyperlipidemias, Liver Transplant Disorder Trial in Moscow (Pitavastatin, PCSK9 inhibitor)

      Recruiting
      • Dyslipidemias
      • +5 more
      • Moscow, Russian Federation
        National Medical Research Centre for Therapy and Preventive Medi
      Sep 8, 2022

      Combined Hyperlipidemia Trial in Moscow, Nizhny Novgorod, Yaroslavl ("Phospholipovit", Placebo)

      Completed
      • Combined Hyperlipidemia
      • Moscow, Russian Federation
      • +2 more
      Feb 14, 2023

      Non-surgical Periodontal Therapy on Severe Periodontitis and

      Recruiting
      • Periodontitis Chronic Generalized Severe
      • +5 more
      • non-surgical periodontal therapy
      • Hangzhou, Zhejiang, China
        2nd Affiliated Hospital, School of Medicine, Zhejiang University
      Sep 17, 2022

      Hyperlipidemias Trial in Boston (Evolocumab, Statins (Cardiovascular Agents))

      Recruiting
      • Hyperlipidemias
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Jul 18, 2022

      Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia Trial in Yongin (Evolocumab 140 MG/ML, Rosuvastatin 5mg, Ezetimibe 10mg)

      Recruiting
      • Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia
      • Evolocumab 140 MG/ML
      • +2 more
      • Yongin, Gyeonggi-do, Korea, Republic of
        Yongcheol Kim
      Jan 6, 2023

      Lipoprotein Lipase Deficiency, Familial Hyperlipoproteinemia Type 1, Familial Hyperchylomicronemia Trial in Berlin

      Active, not recruiting
      • Lipoprotein Lipase Deficiency
      • +2 more
      • Observational study
      • Berlin, Germany
        Interdisciplinary Metabolism Center, Lipid Out-Patient-Clinic, L
      May 9, 2022

      Dyslipidemias, High Cholesterol, Hypercholesterolemia Trial in United States (Obicetrapib, Placebo)

      Recruiting
      • Dyslipidemias
      • +8 more
      • Sarasota, Florida
      • +11 more
      Aug 10, 2022

      Hyperlipidemias, Hypercholesterolemia Trial in Cheras (Placebo, 250 mg OPP)

      Completed
      • Hyperlipidemias
      • Hypercholesterolemia
      • Placebo
      • 250 mg OPP
      • Cheras, WP Kuala Lumpur, Malaysia
        National University of Malaysia
      Apr 5, 2022

      Hyperlipoproteinemia Type I, Hypertriglyceridemia Trial in Dallas (Orlistat)

      Active, not recruiting
      Has Results
      • Hyperlipoproteinemia Type I
      • Hypertriglyceridemia
      • Dallas, Texas
        UT Southwestern Medical Center 5323 Harry Hines Blvd
      Jan 23, 2022

      Hyperlipidemia Trial in Beijing (AK102, Placebo)

      Recruiting
      • Hyperlipidemia
      • AK102
      • Placebo
      • Beijing, China
        Peking University First Hospital
      Feb 15, 2022